Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Active, not recruiting · NCT01366092 · Registry updated 2026-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease | Bronchiolitis Obliterans, Chronic Graft-Versus-Host Disease, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-02-20 | NCT01366092 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| National Cancer Institute (NCI) | 3015 |
| Prometheus Laboratories | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Dana-Farber Cancer Institute | Boston | United States | 1 |
| Massachusetts General Hospital | Boston | United States | 21 |